|
DSpace at RU >
University Library >
Academic bibliography >
Files in This Item:
| File |
Description |
Size | Format |
| publisher's version | 68.54 kB | Adobe PDF | Under Embargo
|
|
| Title: | F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature. |
| Author(s): | Bleeker-Rovers, C.P. (298593254) Jager, G.J. Tack, C.J.J. (155613936) Meer, J.W.M. van der (070708525) Oyen, W.J.G. (09080497X) |
| Publication year: | 2004 |
| Document type: | Article / Letter to editor |
| Journal: | Journal of Internal Medicine |
| ISSN: | 0954-6820 |
| Volume: | vol. 255 |
| Issue: | iss. 3 |
| Start page: | p. 419 |
| End page: | p. 423 |
| Abstract: | Pylephlebitis or septic thrombophlebitis of the portal vein is a serious infectious disorder. Early diagnosis is difficult, due to nonspecific symptoms and signs, limitations of diagnostic modalities and the lack of familiarity of physicians with this entity. We report the history of a 73-year-old man with fever of unknown origin (FUO) in whom laboratory tests, blood and urine cultures, chest X-ray, abdominal ultrasound, and Indium-111-leucocyte scintigraphy did not reveal the cause of the fever. F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) subsequently pointed to the diagnosis of pylephlebitis, which was confirmed by computed tomography (CT) and percutaneous puncture. We conclude that FDG PET allows detecting inflammatory foci in patients with FUO and offers to make the diagnosis of pylephlebitis at an early stage. |
| Subject: | EBP 3: Effective Primary Care and Public Health UMCN 2.2: Vascular medicine and diabetes UMCN 4.1: Microbial pathogenesis and host defense |
| Organization: | Nuclear Medicine Radiology General Internal Medicine |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/58510
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|